| Title |
A randomized, double blind, placebo controlled, multicenter clinical trial to assess the efficacy and safety of Emblica officinalis extract in patients with dyslipidemia
|
|---|---|
| Published in |
BMC Complementary Medicine and Therapies, January 2019
|
| DOI | 10.1186/s12906-019-2430-y |
| Pubmed ID | |
| Authors |
Haridas Upadya, S. Prabhu, Aravinda Prasad, Deepa Subramanian, Swati Gupta, Ajay Goel |
X Demographics
The data shown below were collected from the profiles of 16 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 13% |
| India | 2 | 13% |
| Canada | 1 | 6% |
| Germany | 1 | 6% |
| Switzerland | 1 | 6% |
| Unknown | 9 | 56% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 12 | 75% |
| Practitioners (doctors, other healthcare professionals) | 3 | 19% |
| Scientists | 1 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 131 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 131 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 15 | 11% |
| Student > Bachelor | 15 | 11% |
| Researcher | 13 | 10% |
| Other | 12 | 9% |
| Student > Ph. D. Student | 7 | 5% |
| Other | 20 | 15% |
| Unknown | 49 | 37% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 19 | 15% |
| Nursing and Health Professions | 13 | 10% |
| Pharmacology, Toxicology and Pharmaceutical Science | 12 | 9% |
| Biochemistry, Genetics and Molecular Biology | 10 | 8% |
| Agricultural and Biological Sciences | 6 | 5% |
| Other | 13 | 10% |
| Unknown | 58 | 44% |
Attention Score in Context
This research output has an Altmetric Attention Score of 72. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 February 2024.
All research outputs
#597,756
of 25,418,993 outputs
Outputs from BMC Complementary Medicine and Therapies
#78
of 3,963 outputs
Outputs of similar age
#13,836
of 446,632 outputs
Outputs of similar age from BMC Complementary Medicine and Therapies
#4
of 65 outputs
Altmetric has tracked 25,418,993 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,963 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 446,632 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 65 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.